For procurement managers and formulators in the pharmaceutical industry, understanding the clinical applications of raw materials is essential to ensure proper specifications and compliance. How to give magnesium sulfate in pregnancy is a common medical question, but from a supplier’s perspective, it highlights the need for high-purity magnesium sulfate heptahydrate that meets pharmacopoeia standards. Weifang Hailei Fine Chemical Co., Ltd. provides pharmaceutical-grade magnesium sulfate (MgSO4·7H2O) in crystal, powder, or granular forms, trusted by compounders and drug manufacturers worldwide. This article explores the medical uses, quality requirements, and sourcing of magnesium sulfate, ensuring you can confidently supply this critical ingredient.
Explore our magnesium sulfate product page for full specifications and packaging options.
Magnesium sulfate is an inorganic salt with the formula MgSO4, most commonly encountered as the heptahydrate (MgSO4·7H2O), known as Epsom salt. In pharmaceutical settings, it is valued for its high solubility, bioavailability of magnesium ions, and wide safety margin when properly administered. Beyond its industrial roles in fertilizer and textiles, pharmaceutical-grade magnesium sulfate supports multiple critical therapeutic areas:
Each of these uses demands a raw material that is free from heavy metals, arsenic, and microbial contamination. The difference between an industrial MgSO4 and a pharmaceutical one often lies in impurity profiles and certificate of analysis (CoA) documentation.
From a medical standpoint, how to give magnesium sulfate in pregnancy is a well‑established protocol. Obstetricians administer magnesium sulfate intravenously or intramuscularly to prevent seizures in preeclampsia/eclampsia and as a tocolytic agent to delay preterm labor. Typical regimens include a 4–6 g IV loading dose over 20–30 minutes, followed by a maintenance infusion of 1–2 g per hour. Intramuscular administration follows a 10 g loading dose (5 g in each buttock), with subsequent 5 g injections every 4 hours. These protocols exist in numerous clinical guidelines from organizations like the WHO and ACOG.
For the pharmaceutical raw material buyer, the question “how to give magnesium sulfate in pregnancy” translates into a specification brief: the supplier must provide MgSO4 heptahydrate that meets USP or EP monographs. Purity must be 99.0–100.5% on dried basis, with limits on chloride, arsenic, lead, and iron. Weifang Hailei’s pharmaceutical‑grade magnesium sulfate consistently achieves 99.5% purity and is accompanied by a detailed CoA demonstrating compliance with current pharmacopoeial standards. Our magnesium sulfate heptahydrate is available in crystalline powder or custom particle sizes suitable for direct formulation or sterile filtration.
Why magnesium sulfate in asthma has been studied extensively: magnesium acts as a bronchodilator by inhibiting calcium‑mediated smooth muscle contraction and promoting cyclic AMP production. In acute severe asthma unresponsive to standard therapy, intravenous magnesium sulfate (2 g over 20 minutes) has shown to improve peak expiratory flow and reduce hospital admissions. Nebulized magnesium sulfate combined with salbutamol is also employed in some pediatric protocols.
This application requires sterile, injectable‑grade raw material with endotoxin control. Hailei’s MgSO4 heptahydrate is produced under GMP‑inspired protocols, with bacterial endotoxin testing available upon request. For compounding pharmacies manufacturing IV solutions or nebulization fluids, the ability to provide a consistent, low‑endotoxin grade is crucial. Understanding “why magnesium sulfate in asthma” works enables formulators to select the correct salt form and particle size for rapid dissolution and precise dosing.
Procurement teams often need guidance on how to compute magnesium sulfate quantities for pharmaceutical manufacturing. The key lies in understanding the difference between the heptahydrate and the anhydrous form. MgSO4·7H2O contains approximately 49.8% water, while anhydrous MgSO4 is essentially 100% active. For an IV solution requiring 1 g of anhydrous magnesium sulfate, you would need 2.024 g of the heptahydrate. Formulation calculations typically start with the required magnesium ion dose: MgSO4·7H2O contains 9.7% elemental magnesium by weight.
Example computation for a batch of 1000 vials, each containing 500 mg magnesium sulfate (as the heptahydrate):
Total required MgSO4·7H2O = 1000 × 0.5 kg = 500 kg
If using anhydrous, divide by 0.511 to convert. Hailei’s technical datasheets provide exact assay values and moisture content to aid such calculations. Contact us for bulk orders and we can help you compute the required amount for your production run. Request a quote with your dosage form details, and our team will assist with purity and quantity recommendations.
Over‑the‑counter magnesium sulfate paste, commonly called drawing ointment, is a time‑tested remedy for boils, splinters, and minor skin infections. The benefits of magnesium sulfate paste include its osmotic action that draws out fluids and reduces inflammation, as well as its antimicrobial properties when formulated with additional ingredients like phenol. The paste is made by mixing magnesium sulfate heptahydrate with glycerol, sometimes with a small percentage of phenol as a preservative and analgesic.
For pharmaceutical manufacturers of topical products, the raw magnesium sulfate must be free of sharp crystalline fragments, have consistent particle size distribution to ensure homogeneous mixing, and meet microbial limits for non‑sterile preparations. Hailei offers pharmaceutical‑grade powder specifically milled for paste formulations, with controlled pH and heavy metal content. Whether you produce branded Epsom salts or private‑label drawing paste, our material ensures smooth texture and regulatory compliance.
Understanding the difference between magnesium sulfate and oxide is vital when sourcing for pharmaceutical or nutritional products. Magnesium oxide (MgO) is a powder with high magnesium content (60.3% elemental Mg) but low water solubility. Magnesium sulfate heptahydrate, in contrast, is highly water‑soluble with a lower magnesium content (9.7%). In therapeutic applications, sulfate is preferred when rapid ion availability is required—as in IV solutions or bath salts—while oxide is often used in oral supplements where slower release is acceptable.
Buyers must consider bioavailability, formulation compatibility, and cost. Magnesium sulfate provides faster absorption and is the molecule of choice for emergency settings and topical products, whereas oxide may be selected for sustained‑release oral tablets. Hailei Fine Chemical also supplies magnesium oxide for customers who require both forms, ensuring consistent quality across your supply chain.
When purchasing magnesium sulfate for medical applications, the following quality parameters should be confirmed:
Weifang Hailei Fine Chemical Co., Ltd. provides magnesium sulfate in crystal, granular, and powder forms with purity ranging from 98% for technical use to 99.5% for pharmaceutical applications. Our ISO‑certified production lines and rigorous QC ensure batch‑to‑batch consistency. Whether you need 25‑kg bags or 1000‑kg supersacks, we serve pharmaceutical raw material purchasers, hospital compounders, and OTC product manufacturers worldwide.
Partnering with a reliable supplier for pharmaceutical‑grade magnesium sulfate reduces regulatory risk and ensures continuity. Hailei’s competitive advantages include:
If you need magnesium sulfate for IV solutions, topical pastes, or other pharmaceutical applications, Weifang Hailei Fine Chemical Co., Ltd. is your strategic partner. Contact us today to request a quote or discuss your specific requirements. For more product details, visit our magnesium sulfate product page.